Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)

Approval Number

SIN16091P

Drug Name

CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)

Product Name

CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)

Approval Date

January 29, 2021

Registrant

BAYER (SOUTH EAST ASIA) PTE LTD

Licence Holder

BAYER (SOUTH EAST ASIA) PTE LTD

Regulatory Information

Registrant

BAYER (SOUTH EAST ASIA) PTE LTD

Licence Holder

BAYER (SOUTH EAST ASIA) PTE LTD

Drug Type

Therapeutic

Forensic Classification

General Sale List

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

R06AX13

ATC Item Name

loratadine

Manufacturer Information

Pharmaceutical Manufacturer

BAYER (SOUTH EAST ASIA) PTE LTD

Manufacturers

Delpharm Montréal Inc.

Active Ingredients

Ingredient Name

Loratadine

Strength

5 mg/ 5mL

Drug MonographLoratadine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy